Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jul 11;128(18):3319–3329. doi: 10.1002/cncr.34354

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 American Cancer Society.

This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency.

PMC Copyright notice

Percentage of patients attaining seroconversion after coronavirus disease 2019 booster vaccination by (A) type of vaccine, (B) vaccine concordance between original series and booster, and (C) treatment status at the time of booster administration. The percentage is listed at each bar; whisker bars indicate 95% exact binomial confidence intervals for the proportion estimate; none of the differences were statistically significant, so p values are not listed. Ad26.COV2.S indicates adenovirus serotype 26 against the severe acute respiratory‐coronavirus 2 spike protein; J&J, Johnson & Johnson; mRNA, messenger RNA.